Title Utility of Early Versus Late Androgen Deprivation in Prostate Cancer Patients with Biochemical Relapse
IRB CASE 1811
Hospital Main Campus
- To measure the utility of treatment versus observation in patients with rising PSA
- All patients with rising PSA after definitive treatment of their prostate cancer with no evidence of metastatic disease are eligible for this study.
- The patient population includes patients with biochemical failure who are being followed at Taussig Cancer Institute or at Glickman clinics.
- The patient will be informed that their choice of whether to participate or not will have no influence on their medical care.